Education
About Us
Working with TipRanks
Follow Us
Iconovo AB (SE:ICO)
:ICO
ICO Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.95 - kr8.15
Previous CloseN/A
Volume7.53K
Average Volume (3M)96.96K
Market Cap
kr136.90M
Enterprise Valuekr21.06M
Total Cash (Recent Filing)kr37.01M
Total Debt (Recent Filing)kr6.19M
Price to Earnings (P/E)―
Beta-0.09
Next Earnings
Oct 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.42
Shares Outstanding53,061,250
10 Day Avg. Volume63,785
30 Day Avg. Volume96,960
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.51
Price to Sales (P/S)22.59
P/FCF Ratio-1.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr2.00Price Target Upside-20.95% Downside
Rating ConsensusHold
Number of Analyst Covering0
ICO FAQ
What was Iconovo AB’s price range in the past 12 months?
Iconovo AB lowest stock price was kr0.95 and its highest was kr8.15 in the past 12 months.
What is Iconovo AB’s market cap?
Iconovo AB’s market cap is kr136.90M.
When is Iconovo AB’s upcoming earnings report date?
Iconovo AB’s upcoming earnings report date is Oct 24, 2025 which is in 57 days.
How were Iconovo AB’s earnings last quarter?
Iconovo AB released its earnings results on Jul 14, 2025. The company reported -kr0.42 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.42.
Is Iconovo AB overvalued?
According to Wall Street analysts Iconovo AB’s price is currently Overvalued.
Does Iconovo AB pay dividends?
Iconovo AB does not currently pay dividends.
What is Iconovo AB’s EPS estimate?
Iconovo AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Iconovo AB have?
Iconovo AB has 53,061,250 shares outstanding.
What happened to Iconovo AB’s price movement after its last earnings report?
Iconovo AB reported an EPS of -kr0.42 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.566%.
Which hedge fund is a major shareholder of Iconovo AB?
Currently, no hedge funds are holding shares in SE:ICO
Company Description
Iconovo AB
Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler, as well as provides customized inhalation solutions. It serves generic companies. The company has an agreement with Immune System Regulation AB for the development of an inhaled covid-19 vaccine in Iconovo's inhaler ICOone; and Respiratorius AB (publ) to develop inhalation product to treat COPD. Iconovo AB (publ) was founded in 2013 and is based in Lund, Sweden.
Technical Analysis
SciBase Holding AB
―
Clinical Laserthermia Systems AB Class B
―
Scandinavian Real Heart AB
―
ScandiDos AB
―
Arcoma AB
―